Adaptive Biotechnologies Corp (ADPT) Insider Trading
- $5,244,000.00
- $605,252,992.69
- April 24, 2026
- Julie Rubinstein
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 24, 2026 | COO | 19,060 | $14.02 | Sell | $267,221.20 | |
| April 22, 2026 | COO | 19,060 | $14.13 | Sell | $269,317.80 | |
| April 21, 2026 | COO | 30,941 | $14.66 | Sell | $453,595.06 | |
| April 20, 2026 | COO | 19,060 | $14.55 | Sell | $277,323.00 | |
| April 16, 2026 | COO | 19,060 | $14.18 | Sell | $270,270.80 | |
| April 13, 2026 | COO | 19,060 | $13.15 | Sell | $250,639.00 | |
| April 10, 2026 | COO | 19,060 | $12.77 | Sell | $243,396.20 | |
| April 8, 2026 | Insider | 22,564 | $15.07 | Sell | $340,039.48 | |
| April 8, 2026 | Insider | 10,000 | $14.85 | Sell | $148,500.00 | |
| April 8, 2026 | CEO | 37,263 | $15.19 | Sell | $566,024.97 | |
| April 8, 2026 | COO | 30,941 | $14.83 | Sell | $458,855.03 | |
| April 7, 2026 | COO | 19,060 | $13.56 | Sell | $258,453.60 | |
| April 6, 2026 | CEO | 83,332 | $14.41 | Sell | $1,200,814.12 | |
| March 23, 2026 | COO | 19,060 | $13.83 | Sell | $263,599.80 | |
| March 20, 2026 | COO | 19,060 | $13.37 | Sell | $254,832.20 | |
| March 18, 2026 | COO | 19,060 | $13.18 | Sell | $251,210.80 | |
| March 16, 2026 | COO | 19,060 | $13.41 | Sell | $255,594.60 | |
| March 13, 2026 | COO | 19,060 | $12.96 | Sell | $247,017.60 | |
| March 11, 2026 | Insider | 470,266 | $13.17 | Sell | $6,193,403.22 | |
| March 11, 2026 | CFO | 18,672 | $13.17 | Sell | $245,910.24 | |
| March 11, 2026 | Insider | 30,593 | $14.08 | Sell | $430,749.44 | |
| March 11, 2026 | CEO | 470,167 | $13.17 | Sell | $6,192,099.39 | |
| March 11, 2026 | COO | 141,583 | $13.29 | Sell | $1,881,638.07 | |
| March 11, 2026 | Insider | 63,103 | $13.17 | Sell | $831,066.51 | |
| March 11, 2026 | Insider | 41,338 | $13.17 | Sell | $544,421.46 | |
| March 10, 2026 | COO | 19,460 | $14.68 | Sell | $285,672.80 | |
| March 9, 2026 | COO | 30,941 | $14.79 | Sell | $457,617.39 | |
| March 5, 2026 | COO | 30,941 | $16.00 | Sell | $495,056.00 | |
| March 5, 2026 | Insider | 38,074 | $15.09 | Sell | $574,536.66 | |
| March 3, 2026 | COO | 30,941 | $15.67 | Sell | $484,845.47 | |
| March 3, 2026 | Insider | 14,233 | $16.52 | Sell | $235,129.16 | |
| March 3, 2026 | CEO | 53,083 | $15.52 | Sell | $823,848.16 | |
| March 2, 2026 | Insider | 10,000 | $15.72 | Sell | $157,200.00 | |
| March 2, 2026 | CEO | 289,024 | $15.82 | Sell | $4,572,359.68 | |
| Feb. 27, 2026 | CEO | 182,891 | $15.99 | Sell | $2,924,427.09 | |
| Feb. 4, 2026 | CFO | 2,145 | $18.46 | Sell | $39,596.70 | |
| Feb. 3, 2026 | Insider | 8,120 | $19.00 | Sell | $154,280.00 | |
| May 16, 2025 | CFO | 1,929 | $8.89 | Sell | $17,148.81 | |
| May 1, 2025 | Insider | 68,412 | $7.35 | Sell | $502,828.20 | |
| March 24, 2025 | Insider | 1,698 | $9.00 | Sell | $15,282.00 | |
| March 12, 2025 | Director | 53,000 | $7.59 | Sell | $402,270.00 | |
| March 10, 2025 | Director | 10,000 | $7.05 | Sell | $70,500.00 | |
| March 6, 2025 | Director | 15,664 | $7.94 | Sell | $124,372.16 | |
| March 5, 2025 | CEO | 117,351 | $6.98 | Sell | $819,109.98 | |
| March 5, 2025 | CFO | 10,320 | $6.98 | Sell | $72,033.60 | |
| March 5, 2025 | COO | 59,505 | $6.98 | Sell | $415,344.90 | |
| March 5, 2025 | Insider | 20,875 | $6.99 | Sell | $145,916.25 | |
| Feb. 20, 2025 | CEO | 99,107 | $8.44 | Sell | $836,463.08 | |
| Feb. 18, 2025 | CEO | 211,160 | $8.50 | Sell | $1,794,860.00 | |
| Feb. 14, 2025 | CEO | 158,921 | $8.46 | Sell | $1,344,471.66 |
Insiders are both buying and selling Adaptive Biotechnologies Corp stock.
The insider traders at Adaptive Biotechnologies Corp are: Julie Rubinstein, Chad M Robins, Harlan S Robins, Chad M Cohen, Stacy L Taylor, Sharon Benzeno, R Mark Adams, Francis Lo, Michelle Renee Griffin, Lance Baldo, Nancy Louise Hill, Kyle Piskel, Robert Hershberg, Eric Dobmeier, Jyoti Palaniappan, Tycho Peterson, Charles Sang, Nitin Sood, David E Goel, Viking Global Performance Llc, Chad M. Robins, Global Investors Lp Viking, Harlan S. Robins, Susan Bobulsky, ADAMS R MARK, Chad M. Cohen, Andris A Zoltners, Peter M Neupert, and Michael J Pellini
The most active insider trader at Adaptive Biotechnologies Corp is Julie Rubinstein with 51 trades.
Viking Global Performance Llc has sold the most Adaptive Biotechnologies Corp stock with a total value of $245,448,434.04.
Viking Global Performance Llc has bought the most Adaptive Biotechnologies Corp stock with a total value of $10,000,000.00.
The most recent insider trade for Adaptive Biotechnologies Corp was on April 24, 2026.
The single biggest insider buy for Adaptive Biotechnologies Corp was from Viking Global Performance Llc with a total value of $5,000,000.00 on July 1, 2019.
The single biggest insider sell for Adaptive Biotechnologies Corp was from Global Investors Lp Viking with a total value of $123,800,000.00 on Nov. 11, 2020.
